Jushi Holdings Future Growth
Future criteria checks 0/6
Jushi Holdings is forecast to grow earnings and revenue by 83% and 10.5% per annum respectively while EPS is expected to grow by 83.2% per annum.
Key information
83.0%
Earnings growth rate
83.16%
EPS growth rate
| Pharmaceuticals earnings growth | 18.9% |
| Revenue growth rate | 10.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 30 Jul 2026 |
Recent future growth updates
Recent updates
JUSH: DEA Schedule III Registration Pathway Will Support Future Repricing
Analysts have raised their price target on Jushi Holdings to $1.50 from $1.00 after applying a slightly higher assumed future P/E multiple and making modest adjustments to their long-term revenue growth and profit margin expectations. What’s in the News for Jushi Holdings On June 24, 2026, Jushi Holdings shareholders approved a special resolution at the 2026 Annual General and Special Meeting to proceed with a plan of arrangement involving the continuance and domestication of the company from British Columbia, Canada, to the State of Nevada in the United States.JUSH.F: DEA Schedule III Registrations And U.S. Domestication Will Support Rerating
Analysts have reduced their price target for Jushi Holdings to $1.00 from $1.50, citing updated assumptions that include a slightly higher discount rate, a modestly lower revenue growth outlook, improved profit margin expectations, and a lower future P/E multiple. What’s in the News for Jushi Holdings On June 24, 2026, Jushi Holdings shareholders approved a special resolution at the 2026 Annual General and Special Meeting to move forward with a plan of arrangement under Section 288 of the Business Corporations Act of British Columbia.JUSH.F: DEA Schedule III Registration Framework Will Support Stronger Future Earnings Multiple
Analysts have kept their $1.50 price target on Jushi Holdings unchanged, citing only modest tweaks to assumptions on discount rate, profit margin and future P/E that did not materially shift their valuation view. What's in the News for Jushi Holdings Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the new federal framework following the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.JUSH.F: DEA Registration Pathway Will Support Stronger Future Earnings Multiple
Analysts have reiterated a $1.50 price target for Jushi Holdings, with slightly refined assumptions around discount rate, revenue growth, profit margin and future P/E that keep their overall valuation view broadly unchanged. What's in the News Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the federal framework that follows the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside
Catalysts About Jushi Holdings Jushi Holdings operates state licensed cannabis cultivation, processing and retail facilities across several U.S. markets. What are the underlying business or industry changes driving this perspective?JUSH.F: Higher Revenue Outlook Will Support Stronger Earnings Multiple
Analysts now see fair value for Jushi Holdings at $1.50, compared with the prior $1.00. This reflects updated assumptions for revenue growth, profit margins, discount rate, and future P/E that shift their risk and earnings outlook for the stock.
Adult Use Legalization And Rescheduling Will Reshape Long Term Prospects For This Cannabis Operator
Catalysts About Jushi Holdings Jushi Holdings is a vertically integrated cannabis company focused on retail, cultivation and processing across several U.S. medical and emerging adult use markets. What are the underlying business or industry changes driving this perspective?
Pennsylvania And Virginia Retail And Canopy Expansion Will Open Markets
Expanding retail and canopy space aims to enhance revenue, anticipating market growth from potential adult-use cannabis legalization.Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 377 | 5 | 8 | 14 | 3 |
| 12/31/2027 | 324 | -19 | 2 | 17 | 4 |
| 12/31/2026 | 280 | -47 | -8 | 8 | 4 |
| 6/30/2026 | 272 | -66 | 4 | 22 | N/A |
| 3/31/2026 | 265 | -71 | 1 | 19 | N/A |
| 12/31/2025 | 263 | -69 | 0 | 18 | N/A |
| 9/30/2025 | 260 | -66 | 3 | 19 | N/A |
| 6/30/2025 | 256 | -58 | 3 | 15 | N/A |
| 3/31/2025 | 256 | -47 | 15 | 23 | N/A |
| 12/31/2024 | 258 | -49 | 17 | 22 | N/A |
| 9/30/2024 | 259 | -54 | 14 | 19 | N/A |
| 6/30/2024 | 263 | -59 | 13 | 19 | N/A |
| 3/31/2024 | 265 | -71 | -1 | 7 | N/A |
| 12/31/2023 | 269 | -65 | -14 | -3 | N/A |
| 9/30/2023 | 278 | -188 | -19 | -3 | N/A |
| 6/30/2023 | 286 | -221 | -28 | -6 | N/A |
| 3/31/2023 | 292 | -195 | -56 | -11 | N/A |
| 12/31/2022 | 284 | -202 | -78 | -21 | N/A |
| 9/30/2022 | 273 | -53 | -86 | -17 | N/A |
| 6/30/2022 | 255 | 40 | -102 | -27 | N/A |
| 3/31/2022 | 230 | 31 | -109 | -25 | N/A |
| 12/31/2021 | 209 | 20 | -90 | -14 | N/A |
| 9/30/2021 | 176 | -144 | -86 | -21 | N/A |
| 6/30/2021 | 147 | -213 | -63 | -10 | N/A |
| 3/31/2021 | 114 | -225 | -28 | 1 | N/A |
| 12/31/2020 | 81 | -211 | -35 | -12 | N/A |
| 9/30/2020 | 55 | -71 | -21 | -7 | N/A |
| 6/30/2020 | 33 | -37 | -30 | -16 | N/A |
| 3/31/2020 | 18 | -40 | N/A | -26 | N/A |
| 12/31/2019 | 10 | -31 | N/A | -23 | N/A |
| 9/30/2019 | 5 | -19 | N/A | -27 | N/A |
| 6/30/2019 | 1 | -25 | N/A | -21 | N/A |
| 3/31/2019 | 1 | -15 | N/A | -12 | N/A |
| 12/31/2018 | 1 | -20 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: JUSH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: JUSH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: JUSH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: JUSH's revenue (10.5% per year) is forecast to grow slower than the US market (13.4% per year).
High Growth Revenue: JUSH's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if JUSH's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/15 10:55 |
| End of Day Share Price | 2026/09/15 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jushi Holdings Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Luke Hannan | Canaccord Genuity |
| Sonny Randhawa | Seaport Research Partners |